Prevention of hepatitis C in partners of anti-HCV positive subjects by periodic gammaglobulin administration
Piazza, M.
Bollettino della Societa Italiana di Biologia Sperimentale 66(9): 907-908
1990
ISSN/ISBN: 0037-8771 PMID: 1705805 Document Number: 367589
Since hepatitis C is sexually transmitted, this poses the problem of protecting the anti-HCV negative partners of anti-HCV positive subjects. Since no specific prophylaxis exists for hepatitis C, I suggest that 4 ml of normal human gammaglobulin should be given to the anti-HCV negative partners intramuscularly every two months until a vaccine against hepatitis C virus is available.
Document emailed within 1 workday
Related Documents
Frankel, S.J.; Polmar, S.H.; Grumet, F.C.; Wedner, H.J. 1986: Anti-IgA antibody associated reactions to intravenous gammaglobulin in a patient who tolerated intramuscular gammaglobulin Annals of Allergy 56(5): 436-439Froyshov, O. 1970: Prevention of rhesus immunization by anti D gammaglobulin Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(8): 772-777
van Loghem, J.J. 1979: Recommendations concerning anti-HBs in transfusion blood and application of anti-hepatitis B immunoglobulin concentrations in the prevention of hepatitis B Nederlands Tijdschrift Voor Geneeskunde 123(43): 1874-1875
Börner, P.; Deicher, H.; Ghani, G.; Geldmacher, H.; Kayser, D.; Kahnt, P.; Klang, D.; Klaus, H.; Marks, V.; Nehawandian, O.A. 1971: Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion Geburtshilfe und Frauenheilkunde 31(10): 911-923
Nakamura, Y.; Sada, I.; Tanaka, S.; Nomura, Y.; Shinagawa, S. 1984: Significance of positive direct anti-globulin test for cord blood--in administration of anti-d immunoglobulin for postpartum immunoprophylaxis Nihon Sanka Fujinka Gakkai Zasshi 36(4): 623-625
Lai, M.Y.; Chen, D.S.; Lee, S.C.; Su, I.J.; Yang, P.M.; Hsu, H.C.; Sung, J.L. 1988: Reactivation of hepatitis B virus in anti-HBe-positive chronic active type B hepatitis: molecular and immunohistochemical studies Hepato-Gastroenterology 35(1): 17-21
Thiele, D.L.; DuCharme, L.; Cunningham, M.R.; Mimms, L.T.; Cuthbert, J.A.; Lee, W.M.; Combes, B. 1996: Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients American Journal of Gastroenterology 91(2): 300-308
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Babeş, V.T.; Singeorzean, P.; Stătescu, F.; Tănase, M. 1980: ABO blood group and sex distribution in anti-HBs-positive subjects Virologie 31(4): 317-318
Nassal, M.; Theilmann, L.; Pfaff, E. 1987: Rapid procedure for the detection of hepatitis delta virus RNA in sera of HBsAg-positive and anti-delta-positive patients Arzneimittel-Forschung 37(6): 748-751
Puoti, C.; Stati, T.; Magrini, A.; Rigato, P.; Romagnoli, G.; Rossi, P.; Montagnese, F.; Resta, S. 1997: Liver histology in anti-HCV positive subjects with normal ALT levels Italian Journal of Gastroenterology and Hepatology 29(4): 383-384
Jasiewicz, A.; Jezuita, J.; Zalewska, T. 1974: Successful attempt at anti-Rh immunization prevention by administration of anti-D-Kabi immunoglobulin following incompatible blood transfusion Ginekologia Polska 45(9): 1105-1107
Lenkei, R.; Babeş, T.; Buligescu, L.; Dobre, L. 1976: Anti-polymerized albumin antibodies-a test for the evaluation of hepatic function in HBs Ag-positive subjects Virologie 27(4): 245-252
Ndase, P.; Celum, C.; Campbell, J.; Bukusi, E.; Kiarie, J.; Katabira, E.; Mugo, N.; Tumwesigye, E.; Wangisi, J.; Were, E.; Brantley, J.; Donnell, D.; Baeten, J.M. 2014: Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience Journal of Acquired Immune Deficiency Syndromes 66(2): 206-212
Arase, Y. 1995: Prognosis of anti-HBe positive chronic hepatitis B Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 2): 586-589
Goudeau, A.; Lo, K.J.; Coursaget, P.; Tong, M.J.; Yeh, C.L.; Tsai, Y.T.; Lee, J.K.; Wu, T.C.; Yeh, S.H.; Lee, S.D. 1983: Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization Developments in Biological Standardization 54: 399-404
Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Dragosics, B.; Pesendorfer, F.; Wewalka, F. 1975: Anti-HBsAg-positive acute hepatitis with a severe disease course Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1353-1356
Karasawa, T.; Aizawa, Y.; Zeniya, M.; Toda, G. 1993: Association of pre-core defective HBV mutant with anti-HBe positive chronic hepatitis Nihon Rinsho. Japanese Journal of Clinical Medicine 51(2): 286-291